Physician profile
David Treiman
NPI 1285742791
$35,202.15
in general payments reported to CMS, 2019-2025
8 companies · $930 in 2025
The $930 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,742 · 2020: $23K · 2021: $7,950 · 2022: $284 · 2023: $593 · 2024: $712 · 2025: $930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,234.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $17,733.44 | 2020-2025 | |
| Ucb, INC. | $16,140.04 | 2019-2025 | Fintepla, Briviact |
| Jazz Pharmaceuticals INC. | $494.23 | 2024-2025 | |
| Neuropace, INC. | $339.24 | 2022-2025 | |
| Neurelis, INC. | $239.10 | 2024-2025 | Valtoco |
| Medtronic, INC. | $109.34 | 2023 | Sensight |
| Catalyst Pharmaceuticals, INC. | $81.59 | 2024 | |
| Livanova USA, INC. | $65.17 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Treiman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.